Cargando…

Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue

The Keap1-Nrf2 signaling axis is a validated and promising target for cellular defense and survival pathways. This minireview discusses the potential off-target effects and their impact on future drug development originating from Keap1-targeting small molecules that function as displacement activato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hushpulian, Dmitry M., Ammal Kaidery, Navneet, Ahuja, Manuj, Poloznikov, Andrey A., Sharma, Sudarshana M., Gazaryan, Irina G., Thomas, Bobby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060438/ https://www.ncbi.nlm.nih.gov/pubmed/33897412 http://dx.doi.org/10.3389/fnagi.2021.673205

Ejemplares similares

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease
por: Ahuja, Manuj, et al.
Publicado: (2022)

Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease
por: Ahuja, Manuj, et al.
Publicado: (2021)

Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s Disease
por: Smirnova, Natalya A., et al.
Publicado: (2016)

Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2
por: Popov, Alexander, et al.
Publicado: (2022)

UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis
por: Zhao, Liang, et al.
Publicado: (2022)

Hyperhomocysteinemia-induced death of retinal ganglion cells: The role of Müller glial cells and NRF2
por: Navneet, Soumya, et al.
Publicado: (2019)

Non-canonical Keap1-independent activation of Nrf2 in astrocytes by mild oxidative stress
por: Al-Mubarak, Bashayer R., et al.
Publicado: (2021)

The KEAP1–NRF2 System in Cancer
por: Taguchi, Keiko, et al.
Publicado: (2017)

Keap1/Nrf2 Signaling Pathway
por: Sykiotis, Gerasimos P.
Publicado: (2021)

The status of Nrf2-based therapeutics: current perspectives and future prospects
por: Gazaryan, Irina G., et al.
Publicado: (2016)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
por: Savyuk, Maria, et al.
Publicado: (2020)

Structural basis of Keap1 interactions with Nrf2
por: Canning, Peter, et al.
Publicado: (2015)

Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals
por: Bhattacharjee, Shamee, et al.
Publicado: (2020)

The KEAP1/NRF2 Signaling Pathway in Keratinization
por: Ishitsuka, Yosuke, et al.
Publicado: (2020)

The KEAP1-NRF2 System and Esophageal Cancer
por: Hirose, Wataru, et al.
Publicado: (2022)

Modulation of NRF2/KEAP1 Signaling in Preeclampsia
por: Tossetta, Giovanni, et al.
Publicado: (2023)

Role of multidrug transporters in neurotherapeutics
por: Jose, Manna, et al.
Publicado: (2009)

Neurotherapeutics for ADHD: Do they work?
por: Rubia, Katya
Publicado: (2022)

Physical and Functional Interaction of Sequestosome 1 with Keap1 Regulates the Keap1-Nrf2 Cell Defense Pathway
por: Copple, Ian M., et al.
Publicado: (2010)

Nrf1 to the rescue
por: Ye, Jin
Publicado: (2014)

Interplay of Nrf2 and BACH1 in inducing ferroportin expression and enhancing resistance of human macrophages towards ferroptosis
por: Namgaladze, Dmitry, et al.
Publicado: (2022)

Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity
por: Casares, Laura, et al.
Publicado: (2020)

KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
por: Dinkova-Kostova, Albena T., et al.
Publicado: (2017)

WDR23 regulates NRF2 independently of KEAP1
por: Lo, Jacqueline Y., et al.
Publicado: (2017)

Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway
por: Hassanein, Emad H. M., et al.
Publicado: (2020)

Nrf2/Keap1/ARE signaling: Towards specific regulation
por: Ulasov, Alexey V., et al.
Publicado: (2022)

The KEAP1-NRF2 System in Healthy Aging and Longevity
por: Matsumaru, Daisuke, et al.
Publicado: (2021)

Molecular Basis of the KEAP1-NRF2 Signaling Pathway
por: Suzuki, Takafumi, et al.
Publicado: (2023)

Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway
por: Kidokoro, Kengo, et al.
Publicado: (2023)

Editorial: Glaucoma: In Search of Better Neurotherapeutics
por: Russo, Rossella, et al.
Publicado: (2018)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Updates and advances in multiple sclerosis neurotherapeutics
por: Amin, Moein, et al.
Publicado: (2022)

Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1
por: Reichard, John F., et al.
Publicado: (2007)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
por: Poloznikov, Andrey A., et al.
Publicado: (2021)

Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation
por: Gong, Meiling, et al.
Publicado: (2020)

Genetic hyperactivation of Nrf2 causes larval lethality in Keap1a and Keap1b-double-knockout zebrafish
por: Bian, Lixuan, et al.
Publicado: (2023)

Monitoring Keap1–Nrf2 interactions in single live cells
por: Baird, Liam, et al.
Publicado: (2014)

The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()
por: Kansanen, Emilia, et al.
Publicado: (2013)

The emerging role of the Nrf2–Keap1 signaling pathway in cancer
por: Jaramillo, Melba C., et al.
Publicado: (2013)

The Role of the Keap1/Nrf2 Pathway in the Cellular Response to Methylmercury
por: Kumagai, Yoshito, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7lnhr4ghkgv2kgploj1jv0qbko